Trial Interactive eClinical Solutions

Choose a faster way to launch and manage your global clinical trials, from site identification to close out.

Expedite Your Study
Doctor using a tablet

Scale your clinical operations with industry-leading technology and services.

Trial Interactive is designed to scale and grow with biotech and pharma companies. With eclinical solutions for every stage of the clinical trial lifecycle, our seamlessly connected platform streamlines and automates essential clinical processes across thousands of studies for sponsors, CROs, and sites around the world.

Speed, scalability, and peace of mind: get industry-leading technology and services to stay inspection-ready. Incorporate a platform that provides flexibility and adaptive trial master file processing.

  • AI Portal
    Industry-leading, AI-powered eTMF
  • Tablet
    Mobile eTMF (myTI)
  • Site Solutions
    Site Solutions
  • TMF 2
    TMF Services
  • Star with a tie
    TMF University
Learn More

Expedite site activation and improve oversight with remote site monitoring and mobile-first CTMS.

  • eLearning
    eFeasibility
  • Site Solutions
    Site Solutions
  • Study Start Up
    Study Start-Up
  • Remote Monitoring
    Remote Monitoring
  • CTMS
    CTMS
Learn More

Centralize your document collaboration and management across the clinical lifecycle from creation to indexing in the eTMF.

  • Third Party Integration
    Clinical Study Document Collaboration
  • Document Management
    General Document Management
  • Study Team Training
    Quality Documents and Training Management
Learn More

Reduce risk with remote site and study personnel training. Automatically index training records in the eTMF.

  • eLearning
    LMS and eLearning
  • Cog Certification
    QMS
  • Study Team Training
    Study Team Trainings
  • Human Resources
    Remote Investigator Meetings
Learn More

Controlling Complexity in Clinical Trials

Trial Interactive provides a practical, author-to-archive approach for streamlining clinical operations, reducing risk, and expediting time-to-market. Clinical professionals around the world consistently choose Trial Interactive as their preferred document management and oversight platform.

Reducing IT Burden on Small and Mid-Sized Pharma and Biotech

In this webinar, our Head of Product, Jay Smith, discusses the ways in which a complete and connected eClinical platform can help reduce the IT burden for small to mid-sized pharma and biotechs. Topics covered include regulation, compliance, validation, and change management.

Trusted by Life Sciences Organizations Big and Small

Join TransPerfect's community of over 1,000 life sciences organizations, including pharma, biotech, CROs, IRBs, and agencies.

20230124-lifesciences-resize-v3_0022_400x160px-hologic_logo.png
untitled_design_4.png
20230124-lifesciences-resize-v3_0016_400x160px-bayer_logo.png
20230124-lifesciences-resize-v3_0015_400x160px-merck_logo.png

Ready to Accelerate Timelines, Improve Quality, and Control Costs?

How did you hear about us?
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

News and Press Releases

Our industry experts have in-depth understanding of the challenges, requirements, and goals for life sciences organizations.

AI Governance in Medical Information: What "Human-in-the-Loop" Actually Requires

These days, you can't have a conversation about AI in life sciences without someone invoking "human-in-the-loop." It's become so expected that leaving it out feels like a red flag—a signal that AI governance hasn't been fully considered. The problem isn't the phrase itself. It’s what organizations think it means. When most pharma teams say human-in-the-loop, what they actually have is a human somewhere in the process. That's not an AI governance strategy. And if that ...

AI Governance in Medical Information: What "Human-in-the-Loop" Actually Requires

Libraries in Clinical Outcome Assessments: How Valuable Are They—and Are They the Panacea They’re Claimed to Be?

Speed, cost, and quality are competing priorities in eCOA localization. Discover why translation libraries alone aren't enough, and what combination of proactive licensing, automation, and integrated technology can transform your deployment timelines. ...

From Reactive to Strategic: How AI Is Transforming Medical Information Contact Centers

IntroductionFor decades, Medical Information (MI) has been an essential function within pharma, but largely a reactive one. This is especially true in medical information contact centers, which serve as the first line of support for HCPs and patients. When someone has a...

Is AI Ready to Transform COA Development?

AI is reshaping clinical development, but its greatest value may lie not in replacing human expertise, but rather in augmenting it. Across the drug development pipeline, AI is helping teams analyze vast datasets faster, identify promising compounds earlier, and uncover...

Five Domains the FDA Wants You to Measure in PROs for Cancer—and Why Translation Affects All of Them

In a recent "LifeSci Talks" episode, TransPerfect Global Practice Leader Mark Wade and Signant Health VP and eCOA Scientist Bill Byrom PhD discussed how new FDA guidance is reshaping how sponsors approach patient-reported outcomes (PROs) in cancer clinical trials. PROs...

AI in Medical Information: Challenges, Opportunities, and the Path to Compliant Content at Scale

Medical information teams are being asked to do more with less; faster turnaround, broader content demands, and zero tolerance for inaccuracy. AI offers a way forward, but adoption comes with real challenges: how do you validate accuracy, integrate literature review, and build ...

Xtalks | Improve Recruitment Outcomes Through More Diverse Clinical Trials

Since the advent of artificial intelligence (AI), medical device manufacturers have been early adopters for product enhancements. Now, manufacturers are evaluating their regulated content and other production processes for suitable applications of AI and automation technology. ...